HOME › Research Insight › Key Players in the High Content Screening Market Are Focusing on Launching Innovative Products in Order to Combat the Stiff Competition
Key Players in the High Content Screening Market Are Focusing on Launching Innovative Products in Order to Combat the Stiff Competition
The global HCS market is a technology-driven market. Over the years, the technologies used as well as their adoption by contract research organizations (CROs) and academic and government institutes have witnessed a rapid change. The market demands significant investments in R&D in order to constantly come up with new innovative products and technologies. Through the development of innovative products, the players in the HCS market compete against each other in order to enhance their market shares.
New product launches, followed by expansions are thekey growth strategies adopted by major players in order to ensure their growth in this market. The strategy of new product launches was mainly adopted by Thermo Fisher Scientific, Inc. (U.S.), Molecular Devices (acquired by Danaher Corporation) (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Merck KGaA (Germany), Yokogawa Electric Corporation (Japan), Becton, Dickinson and Company (BD) (U.S.), and Genedata AG (Switzerland).
A number of small and mid-sized emerging players and large players are present in the global HCS market.The degree of competiveness amongst these players is high. Moreover, many new players are entering this market, which is increasing the level of competition. At the same time, existing players are focusing on increasing their product differentiation to reduce competition and maintain their market share.
Thermo Fisher Scientific (U.S.) is the market leader in the HCS instruments market. The company offers a wide range of high content screening products, such as cellular imaging instruments, software, and reagents to a large number of end users including clinical, healthcare, and pharmaceutical companies as well as academic institutions. The company has a well-established international network of warehouses, specialized product vaults, and warehouse management systems, which maintain inventory and coordinate product delivery. In addition, it has 12,600 sales and service personnel including more than 1,000 highly skilled technical specialists who meet the technical needs of the end users.
The HCS consumables market does not have a market leader as the market is fragmented and is shared by many different players. Some of the prominent players in the HCS consumables market are Life Technologies (U.S.), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Molecular Devices (U.S.), Cell Signaling Technologies (U.S.), PerkinElmer (U.S.), GE Healthcare (U.K.), Intellicyt Corporation (U.S.), and Merck KGaA (U.S.).
High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252